These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 9845376

  • 21. Anti-GD3 monoclonal antibody analysis of childhood T-cell acute lymphoblastic leukemia: detection of a target antigen for antibody-mediated cytolysis.
    Reaman GH, Taylor BJ, Merritt WD.
    Cancer Res; 1990 Jan 01; 50(1):202-5. PubMed ID: 2403416
    [Abstract] [Full Text] [Related]

  • 22. Utilization of two different T cell receptors by T cell acute lymphoblastic lymphoma and leukemia.
    Gouttefangeas C, Bensussan A, Boumsell L.
    Nouv Rev Fr Hematol (1978); 1990 Jan 01; 32(5):337-40. PubMed ID: 2099407
    [Abstract] [Full Text] [Related]

  • 23. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J, Shao ZH, Liu H, Bai J, Cao YR, He GS, Tu MF, Wang XL, Hao YS, Yang TY, Yang CL.
    Chin Med J (Engl); 2004 Jul 01; 117(7):963-7. PubMed ID: 15265365
    [Abstract] [Full Text] [Related]

  • 24. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.
    Kozlov I, Beason K, Yu C, Hughson M.
    Cancer Genet Cytogenet; 2005 Nov 01; 163(1):62-7. PubMed ID: 16271957
    [Abstract] [Full Text] [Related]

  • 25. CD117/CD34 expression in leukemic blasts.
    Wells SJ, Bray RA, Stempora LL, Farhi DC.
    Am J Clin Pathol; 1996 Aug 01; 106(2):192-5. PubMed ID: 8712172
    [Abstract] [Full Text] [Related]

  • 26. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Am J Hematol; 2005 May 01; 79(1):26-35. PubMed ID: 15849776
    [Abstract] [Full Text] [Related]

  • 27. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A, Adib M, Mokarian F, Tebianian M, Nassiri R.
    Med Sci Monit; 2003 Aug 01; 9(8):CR359-62. PubMed ID: 12942032
    [Abstract] [Full Text] [Related]

  • 28. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 01; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 29. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE, Cruse JM, Webb RN, Sanders CM, Beason K.
    Exp Mol Pathol; 2007 Oct 01; 83(2):269-73. PubMed ID: 17603036
    [Abstract] [Full Text] [Related]

  • 30. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies.
    Robak T, Korycka A.
    Arch Immunol Ther Exp (Warsz); 1987 Oct 01; 35(1):33-42. PubMed ID: 3477133
    [Abstract] [Full Text] [Related]

  • 31. Aberration antigen expression in adult acute myelocytic leukemias.
    Chen SS, Zhang HF, Xue WT, Li K, Fu JF, Wang DB, Wu PN.
    Chin Med J (Engl); 1993 Jun 01; 106(6):419-22. PubMed ID: 8222892
    [Abstract] [Full Text] [Related]

  • 32. [Classification of acute leukemias according to the first latin-american consensus conference for the immunophenotyping of leukemias].
    Piedras J, Barrales-Benítez O, López-Karpovitch X.
    Rev Invest Clin; 2000 Jun 01; 52(5):524-8. PubMed ID: 11195181
    [Abstract] [Full Text] [Related]

  • 33. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA, Ramachandar K, Taub RN.
    J Clin Invest; 1974 Dec 01; 54(6):1273-8. PubMed ID: 4140196
    [Abstract] [Full Text] [Related]

  • 34. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
    Aota F, Chang D, Hill NO, Khan A.
    Exp Hematol; 1982 Nov 01; 10(10):835-43. PubMed ID: 6759147
    [Abstract] [Full Text] [Related]

  • 35. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED, Kadushin JM, Schacter B, Fanger MW.
    J Immunol; 1982 Mar 01; 128(3):1476-81. PubMed ID: 6948897
    [Abstract] [Full Text] [Related]

  • 36. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Mar 01; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 37. [Monoclonal antibodies in diagnosis of acute leukemias].
    Krawczyńska A, Robak T.
    Przegl Lek; 1996 Mar 01; 53(1):20-5. PubMed ID: 8711170
    [Abstract] [Full Text] [Related]

  • 38. Shifts in expression of immunological cell markers in relapsed acute leukemia.
    Tomová A, Babusíková O.
    Neoplasma; 2001 Mar 01; 48(3):164-8. PubMed ID: 11583283
    [Abstract] [Full Text] [Related]

  • 39. Single step immunophenotyping of acute leukemias not classifiable by standard morphology and cytochemistry: a practical approach.
    Raimondi R, Pellizzari G, Rodeghiero F.
    Haematologica; 1993 Mar 01; 78(6 Suppl 2):66-72. PubMed ID: 8039763
    [Abstract] [Full Text] [Related]

  • 40. Expression of cytokine receptors on different myeloid leukemic cells.
    Koubek K, Kumberová A, Starý J, Babusíková O, Klamová H, Filipec M.
    Neoplasma; 1998 Mar 01; 45(4):198-203. PubMed ID: 9890661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.